These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16299229)

  • 1. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
    Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
    Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
    Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
    Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.
    Kokkinos MI; Wafai R; Wong MK; Newgreen DF; Thompson EW; Waltham M
    Cells Tissues Organs; 2007; 185(1-3):191-203. PubMed ID: 17587825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of epithelial-mesenchymal transition in breast cancer.
    Fuchs IB; Lichtenegger W; Buehler H; Henrich W; Stein H; Kleine-Tebbe A; Schaller G
    Anticancer Res; 2002; 22(6A):3415-9. PubMed ID: 12530097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines.
    Sommers CL; Heckford SE; Skerker JM; Worland P; Torri JA; Thompson EW; Byers SW; Gelmann EP
    Cancer Res; 1992 Oct; 52(19):5190-7. PubMed ID: 1382837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
    Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer.
    Sun B; Zhang S; Zhang D; Li Y; Zhao X; Luo Y; Guo Y
    Clin Cancer Res; 2008 Nov; 14(21):7050-9. PubMed ID: 18981002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival.
    Alge CS; Hauck SM; Priglinger SG; Kampik A; Ueffing M
    J Proteome Res; 2006 Apr; 5(4):862-78. PubMed ID: 16602694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines.
    Williams K; Chubb C; Huberman E; Giometti CS
    Electrophoresis; 1998 Feb; 19(2):333-43. PubMed ID: 9548300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
    Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
    Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
    Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE
    Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLC-beta2 is highly expressed in breast cancer and is associated with a poor outcome: a study on tissue microarrays.
    Bertagnolo V; Benedusi M; Querzoli P; Pedriali M; Magri E; Brugnoli F; Capitani S
    Int J Oncol; 2006 Apr; 28(4):863-72. PubMed ID: 16525635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High HSP90 expression is associated with decreased survival in breast cancer.
    Pick E; Kluger Y; Giltnane JM; Moeder C; Camp RL; Rimm DL; Kluger HM
    Cancer Res; 2007 Apr; 67(7):2932-7. PubMed ID: 17409397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction.
    Bianchi L; Canton C; Bini L; Orlandi R; Ménard S; Armini A; Cattaneo M; Pallini V; Bernardi LR; Biunno I
    Proteomics; 2005 Jun; 5(9):2433-42. PubMed ID: 15880780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.